ISRCTN57941461已完成不适用
A Randomised, Prospective, Double Blinded, Placebo Controlled Trial to Determine the Efficacy of Continuous Infusion Ankle Block Compared to Standard Single Bolus Block in the Management of Postoperative Pain Following Foot and Ankle Surgery
Record Provided by the NHSTCT Register - 2006 Update - Department of Health0 个研究点目标入组 56 人开始时间: 2006年9月29日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients undergoing ankle and hindfoot surgery.
排除标准
- •1. Dementia
- •2. Peripheral neuropathy
研究者
相似试验
进行中（未招募）
1 期
A Randomised, Prospective, Double Blinded, Placebo Controlled Trial to Determine the Efficacy of Continuous Infusion Ankle Block Compared to Standard Single Bolus Block in the Management of Postoperative Pain Following Foot and Ankle Surgery - Ankle Block StudyAny Orthopaedic condition which would require ankle or hind foot surgery under Mr. James Calder at North Hampshire Hospital, Basingstoke.EUCTR2005-006172-35-GBorth Hampshire Hospital NHS Trust56
已完成
不适用
Study of nutraceutical formulation in healthy subjects with mild damage of lung function due to long term exposure to polluted environment.CTRI/2018/10/016195Amway India Enterprises Pvt Ltd56
已完成
不适用
A study to assess effects of Nutraceutical formulations in Pre-diabetic Subjects.CTRI/2018/09/015586Amway India Enterprises Pvt Ltd56
进行中（未招募）
1 期
Planned, randomized trial where placebo is used and the drug. No one would know which subject has the drug and which one has placebo. Trial is phase 3 study and will study how safe and effective the drug is with subjects who have Advanced or Metastatic Gastric Cancer (GC)Advanced or Metastatic Gastric CancerEUCTR2016-003984-20-PLSK BioPartners, Inc459
进行中（未招募）
1 期
Planned, randomized trial where placebo is used and the drug. No one would know which subject has the drug and which one has placebo. Trial is phase 3 study and will study how safe and effective the drug is with subjects who have Advanced or Metastatic Gastric Cancer (GC)Advanced or Metastatic Gastric CancerEUCTR2016-003984-20-DEElevar Therapeutics, Inc459